The integration of GLP-1 based treatments with other gut hormone actions offers a promising future in managing obesity and its associated diseases more effectively
While we believe the PCAC meeting increases the likelihood of policy changes, those changes are not guaranteed, and new policies could come with limitations
(PubMed) Almeida OP, Marsh K, Alfonso H, Flicker L, Davis TM, Hankey GJ
For patients who prefer non-injectable options , having multiple formulation choices from a single provider simplifies the process considerably
In the U.S., list prices for GLP-1-based medications are up to $1,000 or more a month before insurance
Limit caffeine after noon